Search Results

There are 16390 results for: content related to: Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsia

  1. You have free access to this content
    2016 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 68, Issue S10, October 2016, Pages: 1–4550,

    Version of Record online : 8 NOV 2016, DOI: 10.1002/art.39977

  2. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  3. You have free access to this content
    2017 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 69, Issue S10, October 2017, Pages: 1–4426,

    Version of Record online : 27 SEP 2017, DOI: 10.1002/art.40321

  4. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  5. You have free access to this content
    Etanercept for the treatment of rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Anne Lethaby, Maria Angeles Lopez-Olivo, Lara J Maxwell, Amanda Burls, Peter Tugwell and George A Wells

    Published Online : 31 MAY 2013, DOI: 10.1002/14651858.CD004525.pub2

  6. You have free access to this content
    Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Ahmed Kotb, Robin Christensen, Amy S Mudano, Lara J Maxwell, Nipam P Shah, Peter Tugwell and George A Wells

    Published Online : 13 MAY 2016, DOI: 10.1002/14651858.CD012183

  7. You have free access to this content
    Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA)

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Amy S Mudano, Peter Tugwell and George A Wells

    Published Online : 17 NOV 2016, DOI: 10.1002/14651858.CD012437

  8. You have free access to this content
    ACR/ARHP scientific abstracts

    Arthritis & Rheumatism

    Volume 42, Issue S9, September 1999, Pages: S71–S407,

    Version of Record online : 9 MAY 2012, DOI: 10.1002/art.1780422107

  9. You have free access to this content
    Management of coccidioidomycosis in patients receiving biologic response modifiers or disease-modifying antirheumatic drugs

    Arthritis Care & Research

    Volume 64, Issue 12, December 2012, Pages: 1903–1909, Sara Taroumian, Susan L. Knowles, Jeffrey R. Lisse, James Yanes, Neil M. Ampel, Austin Vaz, John N. Galgiani and Susan E. Hoover

    Version of Record online : 28 NOV 2012, DOI: 10.1002/acr.21784

  10. Tocilizumab for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Jasvinder A Singh, Saba Beg and Maria Angeles Lopez-Olivo

    Published Online : 7 JUL 2010, DOI: 10.1002/14651858.CD008331.pub2

  11. You have free access to this content
    Use of disease-modifying medications for rheumatoid arthritis by race and ethnicity in the National Ambulatory Medical Care Survey

    Arthritis Care & Research

    Volume 64, Issue 2, February 2012, Pages: 184–189, Daniel H. Solomon, John Z. Ayanian, Ed Yelin, Tamara Shaykevich, M. Alan Brookhart and Jeffrey N. Katz

    Version of Record online : 25 JAN 2012, DOI: 10.1002/acr.20674

  12. You have free access to this content
    Use and Spending for Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among US Medicare Beneficiaries

    Arthritis Care & Research

    Volume 67, Issue 9, September 2015, Pages: 1210–1218, Jinoos Yazdany, Chris Tonner and Gabriela Schmajuk

    Version of Record online : 26 AUG 2015, DOI: 10.1002/acr.22580

  13. Patterns of Systemic Treatment for Psoriatic Arthritis in the United States: 2004-2015

    Arthritis Care & Research

    Accepted manuscript online: 13 AUG 2017, Moa P. Lee, Joyce Lii, Yinzhu Jin, Rishi J. Desai, Daniel H. Solomon, Joseph F. Merola and Seoyoung C. Kim

    DOI: 10.1002/acr.23337

  14. Changes in peripheral blood B cell subsets at diagnosis and after treatment with disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: correlation with clinical and laboratory parameters

    International Journal of Rheumatic Diseases

    Volume 18, Issue 4, May 2015, Pages: 421–432, Jeremy McComish, Joy Mundy, Tom Sullivan, Susanna M. Proudman and Pravin Hissaria

    Version of Record online : 2 MAR 2014, DOI: 10.1111/1756-185X.12325

  15. You have free access to this content
    Association of Socioeconomic Status With Treatment Delays, Disease Activity, Joint Damage, and Disability in Rheumatoid Arthritis

    Arthritis Care & Research

    Volume 67, Issue 7, July 2015, Pages: 940–946, Emily Molina, Inmaculada del Rincon, Jose Felix Restrepo, Daniel F. Battafarano and Agustin Escalante

    Version of Record online : 25 JUN 2015, DOI: 10.1002/acr.22542

  16. You have free access to this content
    Poster Presentation Abstracts

    International Journal of Rheumatic Diseases

    Volume 19, Issue S2, September 2016, Pages: 21–293,

    Version of Record online : 19 SEP 2016, DOI: 10.1111/1756-185X.12962

  17. Has the use of disease-modifying anti-rheumatic drugs changed as a consequence of controlled access to high-cost biological agents through the Pharmaceutical Benefits Scheme?

    Internal Medicine Journal

    Volume 37, Issue 9, September 2007, Pages: 601–606, C. Y. Lu, K. M. Williams and R. O. Day

    Version of Record online : 2 JUN 2007, DOI: 10.1111/j.1445-5994.2007.01396.x

  18. You have free access to this content
    Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations

    Arthritis & Rheumatism

    Volume 64, Issue 3, March 2012, Pages: 630–638, Leslie R. Harrold, J. Timothy Harrington, Jeffrey R. Curtis, Daniel E. Furst, Mary Jane Bentley, Ying Shan, George Reed, Joel Kremer and Jeffrey D. Greenberg

    Version of Record online : 28 FEB 2012, DOI: 10.1002/art.33380

  19. Methotrexate monotherapy versus methotrexate combination therapy with non-biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Wanruchada Katchamart, Judith Trudeau, Veerapong Phumethum and Claire Bombardier

    Published Online : 14 APR 2010, DOI: 10.1002/14651858.CD008495

  20. You have full text access to this OnlineOpen article
    Patients' attitudes and experiences of disease-modifying anti-rheumatic drugs in rheumatoid arthritis and spondyloarthritis: A qualitative synthesis

    Arthritis Care & Research

    Accepted manuscript online: 21 JUL 2017, Ayano Kelly, Kathleen Tymms, David J Tunnicliffe, Daniel Sumpton, Chandima Perera, Kieran Fallon, Jonathan C. Craig, Walter Abhayaratna and Allison Tong

    DOI: 10.1002/acr.23329